Granules India’s wholly-owned foreign subsidiary, Granules Pharmaceuticals, Inc. (GPI), has received final approval from the US Food & Drug Administration (FDA) for its Abbreviated New Drug ...

Considering today's low, the Nifty pharma index has fallen over 7 per cent in the last three days. On a monthly scale, the index has declined nearly 12 per cent against a 3 per cent fall in the ...

Granules India Ltd share price was down by -1.44% from the previous closing price of ₹564.45. Who are peers of Granules India Ltd? The peers of Granules India Ltd are Sun Pharmaceuticals ...

With granules so fine they’re almost imperceptible, the formula feels more like a standard face wash, leaving your skin deeply cleansed yet noticeably soothed and refreshed. Gentle enough for ...

The product launches that were supposed to happen from Granules India’s Gagillapur facility in Hyderabad will be delayed by two quarters due to the closure of the plant, the company’s Executive ...

Granules India receives USFDA approval for its generic Lisdexamfetamine Dimesylate capsules, indicated for the treatment of ADHD and Binge Eating Disorder in adults and children. Jan 30, 2025 14:05 ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

Granules India Ltd., incorporated in the year 1991, is a Mid Cap company (having a market cap of Rs 13,703.32 Crore) operating in Pharmaceuticals sector. Granules India Ltd. key Products/Revenue ...

SC3102.med.buffalo.edu Objective To inspect cigarettes with a triple granular filter for charcoal granules on the cut filter surface and, if present, to determine whether the charcoal granules on the ...